Company Analysis

Trulieve Cannabis Corp. (TRLV)

NYSE: TRLV · Medicinal Chemicals & Botanical Products · Tallahassee, FL · filing with the SEC since 2018
Grade5.5
◀ Past 5.2● Present 6.0▶ Future 5.0

Filings

195 filings since 2017 beside 221 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Jun 25, 2026.

Filings a yearinsider forms included
14866456886552
20182020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Jul 2, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 29, 2024.
Insider forms 221

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 24, 2026 S-8 POS Employee stock plan update
Aug 24, 2026 POSASR Automatic shelf amended
Aug 11, 2026 8-K items 1.01, 3.02, 3.03, 5.03, 9.01 Major agreement signed; Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Aug 7, 2026 8-K items 2.01, 7.01, 9.01 Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Aug 5, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report
Jul 8, 2026 SCHEDULE 13G Large holder notice
Jul 2, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jun 30, 2026
Jun 25, 2026 DEFA14A Extra proxy material
Jun 25, 2026 DEF 14A Proxy statement
Jun 12, 2026 PRE 14A Preliminary proxy statement Jun 8, 2026
Jun 12, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jun 11, 2026
Jun 11, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 9, 2026
Jun 9, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 9, 2026 8-A12B Class of securities registered for listing
Jun 9, 2026 CERT Exchange listing certification
Jun 4, 2026 8-K items 1.01, 2.01, 9.01 Major agreement signed; Purchase or sale of a business completed · Current report Jun 3, 2026
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 29, 2026 DEFA14A Extra proxy material
Apr 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 29, 2026 DEF 14A Proxy statement Dec 31, 2025
Apr 21, 2026 8-K item 5.02 Officer or director change · Current report Apr 15, 2026
Mar 5, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Feb 27, 2026
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 18, 2026 8-K item 5.02 Officer or director change · Current report Feb 12, 2026
Feb 6, 2026 D Private placement notice
Jan 29, 2026 8-K items 1.01, 2.03, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Other event · Current report
Dec 29, 2025 D Private placement notice
Dec 18, 2025 SCHEDULE 13G Large holder notice
Dec 17, 2025 8-K items 1.01, 2.03, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Other event · Current report
Dec 9, 2025 8-K items 8.01, 9.01 Other event · Current report Dec 8, 2025
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 4, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 27, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
40 of 195 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TRLV · research, not advice